Invention Grant
- Patent Title: Anti-cancer oncolytic virus combination therapies and elite responder selection platforms
-
Application No.: US15744295Application Date: 2017-03-28
-
Publication No.: US11433108B2Publication Date: 2022-09-06
- Inventor: Minjie Hu , Yu Li , Xiaoling Liu , Rebecca Hu
- Applicant: Minjie Hu , Yu Li , Xiaoling Liu , Rebecca Hu
- Applicant Address: US CA Foster City; US GA Johns Creek; US TX Pearland; US CA Foster City
- Assignee: Minjie Hu,Yu Li,Xiaoling Liu,Rebecca Hu
- Current Assignee: Minjie Hu,Yu Li,Xiaoling Liu,Rebecca Hu
- Current Assignee Address: US CA Foster City; US GA Johns Creek; US TX Pearland; US CA Foster City
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- International Application: PCT/US2017/024471 WO 20170328
- International Announcement: WO2017/172713 WO 20171005
- Main IPC: A61K35/768
- IPC: A61K35/768 ; A61K39/39 ; A61K35/745 ; A61P35/00 ; A61K35/741 ; A61K45/06 ; C12N7/00 ; A61K39/00

Abstract:
Therapeutic methods for administering gut microbiota and oncolytic viruses to a subject are provided. The gut microbiota serve to pre-condition, the subject's immune system to antitumor responses and augments anticancer activity of the oncolytic vims. Combinations of the gut. microbiota and viruses and uses thereof for treating and preventing cancer are provided. The present disclosure also provides methods for building elite responder selection platforms through hierarchical clustering analysis of genomic profiles for human gut microbiome.
Public/Granted literature
- US20190000899A1 ANTI-CANCER ONCOLYTIC VIRUS COMBINATION THERAPIES AND ELITE RESPONDER SELECTION PLATFORMS Public/Granted day:2019-01-03
Information query
IPC分类: